ChongQing Zhengchuan Pharmaceutical Packaging Co LtdLower selling prices and higher raw material costs reduced profitability despite revenue growth.

Zhengchuan Shares released its 2026 interim report on August 28. First-half operating revenue was 381 million yuan, up 17.6% year-on-year, but net profit attributable to the parent was 12.29 million yuan, down 12.8% year-on-year, and net profit attributable to the parent after deducting non-recurring items was 7.08 million yuan, down 30.7% year-on-year. In the second quarter, operating revenue was 172 million yuan, up 6.1% year-on-year, net profit attributable to the parent was 5.46 million yuan, up 72.0% year-on-year, and net profit attributable to the parent after deducting non-recurring items was 1.75 million yuan, up 48.4% year-on-year. The company said the profit decline was mainly due to lower selling prices for some products and rising raw material procurement costs, including year-on-year increases in prices of raw materials such as borax, aluminum strip, and rubber stoppers, as well as higher natural gas costs. In addition, intensifying industry homogenization and continued price-cut pressure transmitted by centralized procurement policies meant that although sales volume and operating revenue grew year-on-year, profitability came under phased pressure.
ChongQing Zhengchuan Pharmaceutical Packaging Co LtdLower selling prices and higher raw material costs reduced profitability despite revenue growth.